Lemaitre Vascular (LMAT) Return on Sales (2016 - 2025)
Lemaitre Vascular (LMAT) has disclosed Return on Sales for 16 consecutive years, with 0.48% as the latest value for Q4 2025.
- On a quarterly basis, Return on Sales fell 68.0% to 0.48% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.1%, a 10.0% decrease, with the full-year FY2025 number at 0.03%, down 16.0% from a year prior.
- Return on Sales was 0.48% for Q4 2025 at Lemaitre Vascular, down from 0.37% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.37% in Q3 2025 to a low of 0.59% in Q4 2023.
- A 5-year average of 0.12% and a median of 0.18% in 2021 define the central range for Return on Sales.
- Peak YoY movement for Return on Sales: tumbled -78bps in 2023, then soared 78bps in 2024.
- Lemaitre Vascular's Return on Sales stood at 0.15% in 2021, then rose by 25bps to 0.19% in 2022, then tumbled by -410bps to 0.59% in 2023, then surged by 133bps to 0.19% in 2024, then crashed by -352bps to 0.48% in 2025.
- Per Business Quant, the three most recent readings for LMAT's Return on Sales are 0.48% (Q4 2025), 0.37% (Q3 2025), and 0.28% (Q2 2025).